Dodecanoylcarnitine
Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease. Dodecanoylcarnitine deomonstrates high sensitivities and specificities in predicting asthma[1][2].
Product Specifications
CAS Number
[25518-54-1]
Product Name Alternative
(-) -Lauroylcarnitine
UNSPSC
12352211
Hazard Statement
H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Dodecanoylcarnitine.html
Purity
99.75
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
Molecular Formula
C19H37NO4
Molecular Weight
343.50
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
POLE3, NT (DNA Polymerase epsilon Subunit 3, DNA Polymerase II Subunit 3, DNA Polymerase epsilon Subunit p17, Chromatin Accessibility Complex 17kD Protein, HuCHRAC17, CHRAC-17, Arsenic-transactivated Protein, AsTP, CHRAC17) (PE)
POLE3, NT (DNA Polymerase epsilon Subunit 3, DNA Polymerase II Subunit 3, DNA Polymerase epsilon Subunit p17, Chromatin Accessibility Complex 17kD Protein, HuCHRAC17, CHRAC-17, Arsenic-transactivated Protein, AsTP, CHRAC17) (PE)
